Clinical trial
Study of Verapamil in Refractory Epilepsy
NCT01126307 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Verapamil in Refractory Epilepsy
- Lead sponsor
- University Health Network, Toronto
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2010
- Completion date
- December 31, 2012
- Enrollment
- 16 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.